Pure Global
NCT06415552

Implementation of Online Mindfulness-Based Stress Reduction Tailored for People With Multiple Sclerosis

Robert Simpson·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Multiple Sclerosis
Drug/Device/Intervention
Mindfulness-Based Stress Reduction
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Robert Simpson
Funder
Unity Health Toronto
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2024
End date
May 31, 2027
Enrollment
120 participants
Primary outcome

Recruitment,Retention,Adherence,Follow-up rates

Summary

This project aims to implement and investigate a mindfulness-based stress reduction (MBSR) in
 people with multiple sclerosis (PwMS). The main objective is to implement MBSR intervention
 for PwMS in a major tertiary care clinic for PwMS. We will iteratively refine the
 intervention as required based on stakeholder feedback and any other emergent contextual
 findings.
 
 Participants will be asked to take part in an 8-week MBSR course and report changes in
 anxiety, depression, quality of life, emotional regulation, self-compassion, mindfulness, and
 health services use.

ICD-10 classifications
Multiple sclerosisProgressive systemic sclerosisSystemic sclerosisSystemic sclerosis, unspecifiedDiffuse sclerosis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06415552
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06415552 through Pure Global AI's free database. This phase not specified trial is sponsored by Robert Simpson and is currently Not yet recruiting. The study focuses on Multiple Sclerosis. Target enrollment is 120 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.